About (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol
(3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol (PubChem CID 129483373) has the molecular formula C14H20BrN3O2
and a molecular weight of 342.24 g/mol. Its IUPAC name is (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol.
Analyze (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol?
The IUPAC name of (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol (CID 129483373) is (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol.
What is the SMILES notation for (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol?
The canonical SMILES for (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol is C[C@]1(O)CCOC[C@H]1[C@H]1CCCN1c1ncc(Br)cn1.
What is the InChIKey of (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol?
The InChIKey is UUPCGTPZNGWONB-SCRDCRAPSA-N. The full InChI is InChI=1S/C14H20BrN3O2/c1-14(19)4-6-20-9-11(14)12-3-2-5-18(12)13-16-7-10(15)8-17-13/h7-8,11-12,19H,2-6,9H2,1H3/t11-,12+,14-/m0/s1.
What are the key properties of (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol?
(3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol has a molecular weight of 342.24 g/mol, XLogP of 2.00, 2 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R,4S)-3-[(2R)-1-(5-bromopyrimidin-2-yl)pyrrolidin-2-yl]-4-methyloxan-4-ol is sourced from PubChem (CID 129483373), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).